Difference in nutritional risk between mild cognitive impairment group and normal cognitive function elderly group

Archives of Gerontology and Geriatrics

Volumn 49, Issue 1, 2009, Pages 49-53

  Lee, Kang Soo ^a,b   Hong, Chang Hyung ^c   Cheong, Hae Kwan ^d   Oh, Byoung Hoon ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Mild cognitive impairment; Nutritional risk; Nutritional screening initiative checklist

Indexed keywords

APOLIPOPROTEIN E; GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; COGNITION; CONTROLLED STUDY; FEMALE; GENOTYPE; GERIATRIC DEPRESSION SCALE; GLUCOSE BLOOD LEVEL; HEARING ACUITY; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL;

AGED; APOLIPOPROTEINS E; BODY MASS INDEX; COGNITION DISORDERS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NUTRITION DISORDERS; NUTRITIONAL STATUS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 67349170433     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2008.04.011     Document Type: Article

References (25)

1. Bae J.N., and Cho M.J. Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients. J. Psychosom. Res. 57 (2004) 297-305
2. Brenner S.R. Vitamin E treatment affects the progression of mild cognitive impairment to dementia. Arch. Neurol. 60 (2003) 292-303
3. Burns A., and Zaudig M. Mild cognitive impairment in older people. Lancet 360 (2002) 1963-1965
4. Cotman C.W., Head E., Muggenburg B.A., Zicker S., and Milgram N.W. Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction. Neurobiol. Aging 23 (2002) 809-818
5. Donini L.M., De Felice M.R., and Cannella C. Nutritional status determinants and cognition in the elderly. Arch. Gerontol. Geriatr. 44 Suppl.1 (2007) 143-153
6. Earnst K.S., Wadley V.G., Aldridge T.M., Steenwyk A.B., Hammond A.E., Harrell L.E., and Marson D.C. Loss of financial capacity in Alzheimer's disease: the role of working memory. Aging Neuropsychol. Cogn. 8 (2001) 109-119
7. Engelhart M.J., Geerlings M.I., Ruitenberg A., Van Swieten J.C., Hofman A., Witteman J.C., and Breteler M.M. Diet and risk of dementia: does fat matter? The Rotterdam Study. Neurology 29 (2002) 1915-1921
8. Feliziani, F.T., Mariani, E., Ercolani, S., Caputo, M., Rinaldi, P., Monastero, R., Senin U., Mecocci, P., 2006. Functional decline in Mild Cognitive Impairment. Results from the ReGAl project, 10th ICAD, Madrid.
9. Ganguli M. Mild cognitive impairment and the 7 uses of epidemiology. Alzheimer Dis. Assoc. Disord. 20 (2006) 52-57
10. Kruman I.I., Kumaravel T.S., Lohani A., Pedersen W.A., Cutler R.G., Kruman Y., Haughey N., Lee J., Evans M., and Mattson M.P. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22 (2002) 1752-1762
11. Lee K.S., Cheong H.K., Kim E.A., Kim K.R., Oh B.H., and Hong C.H. Nutritional risk and cognitive impairment in the elderly. Arch. Gerontol. Geriatr. 48 (2009) 95-99
12. Association in collaboration with the World Health Organization, and Levy R. Aging-associated cognitive decline. Working party of the international psychogeriatric. Int. Psychogeriatry 6 (1994) 63-68
13. Lockhart B.P., and Lestage P.J. Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: Why? When? Which?. Exp. Gerontol. 38 (2003) 119-128
14. Marson D.C., Sawrie S.M., Snyder S., McInturff B., Stalvey T., Boothe A., Aldridge T., Chatterjee A., and Harrell L.E. Assessing financial capacity in patients with Alzheimer disease: a conceptual model and prototype instrument. Arch. Neurol. 27 (2000) 877-884
15. Masaki K.H., Losonczy K.G., Izmirlian G., Foley D.J., Ross G.W., Petrovitch H., Havlik R., and White L.R. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 54 (2000) 1265-1272
16. Mecocci P., Mariani E., Cornacchiola V., and Polidori M.C. Antioxidants for the treatment of mild cognitive impairment. Neurol. Res. 26 (2004) 598-602
17. Peres K., Chrysostome V., Fabrigoule C., Orgogozo J.M., Dartigues J.F., and Barberger-Gateau P. Restriction in complex activities of daily living in MCI: impact on outcome. Neurology 67 (2006) 461-466
18. Perneczky R., Pohl C., Sorg C., Hartmann J., Tosic N., Grimmer T., Heitele S., and Kurz A. Impairment of activities of daily living requiring memory or complex reasoning as part of the MCI syndrome. Int. J. Geriatr. Psychiatry 21 (2006) 158-162
19. Petersen R.C., Thomas R.G., Grundman M., Bennett D., Doody R., Ferris S., Galasko D., Jin S., Kaye J., Levey A., Pfeiffer E., Sano M., Van Dyck C.H., and Thal L.J. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med 352 (2005) 2379-2388
20. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., and Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 58 (2001) 1985-1992
21. Posner B.M., Jette A.M., Smith K.W., and Miller D.R. Nutrition and health risks in the elderly: the nutrition screening initiative. Am. J. Public Health 83 (1993) 972-978
22. Qin B., Cartier L., Dubois-Dauphin M., Li B., Serrander L., and Krause K.H. A key role for the microglial NADPH oxidase in APP-dependent killing of neurons. Neurobiol. Aging 27 (2006) 1577-1587
23. Vellas B., Lauque S., Gillette-Guyonnet S., Andrieu S., Cortes F., Nourhashémi F., Cantet C., Ousset P.J., Grandjean H., and REAL.FR Group. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinestrease inhibitor treatment. J. Nutr. Health Aging 9 (2005) 75-80
24. Wadley V.G., Harrell L.E., and Marson D.C. Self- and informant report of financial abilities in patients with Alzheimer's disease. Reliable and valid?. J. Am. Geriatr. Soc. 51 (2003) 1621-1626
25. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., Nord-berg A., Backman L., Albert M., Almkvist O., Arai H., Basun H., Blennow K., De Leon M., DeCarli C., Erkinjuntti T., Giacobini E., Graff C., Hardy J., Jack C., Jorm A., Ritchie K., Van Duijn C., Visser P., and Petersen R.C. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 256 (2004) 240-246